Intermediate organisations: a solution for `solidaristic' health systems?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.262, 2000-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems?

By Adam La Caze

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 445-447

Adis International

Access to resources Recommend Favorite

What Can Consumer Adverse Drug Reaction Reporting Add to Existing Health Professional-Based Systems?: Focus on the Developing World

By Fernandopulle R.B.M. Weerasuriya K.

Drug Safety, Vol. 26, Iss. 4, 2003-01 ,pp. : 219-225

Adis International

Access to resources Recommend Favorite

Public & private health systems: on the same (balance) sheet?

Inpharma, Vol. 1, Iss. 1592, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Public & private health systems: on the same (balance) sheet?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 530, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Complex systems vs reductionism?

Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite